Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support... see more

PINL:GRPOF - Post Discussion

Traxion Sab De Cv Ord Shs > On Nuuvera and GMP certification
View:
Post by Brassnut on Jan 29, 2018 2:33pm

On Nuuvera and GMP certification

Tetra is waiting on Aphria to get GMP certification before Health Canada will approve phase 3 ppp001 as per this... https://m.marketwired.com/press-release/tetra-bio-pharma-provides-update-on-status-its-phase-3-clinical-trial-application-lead-2242969.htm And this was part of the news release today... Provides Access to State-of-the-Art Testing and Extraction Facilities: The combined company, through Nuuvera, has access to the only standalone Health Canada GMP-approved facility that is authorized and dedicated under its controlled drugs and substances licence to conduct commercial scale activities with respect to cannabis and cannabinoids. This state-of-the-art medical laboratory enables Nuuvera to maintain the highest standards by adhering to both Health Canada and FDA pharmaceutical GMP guidelines, ensuring product safety, quality, and efficacy. Sounds like that GMP certification just came through!
Comment by TheBossCwC on Jan 29, 2018 3:51pm
great DD, I just want to make sure I have connected the dots... Tetra on a GMP certified lab for PPP0001 Tetra received approval for the ethics review board on November 6th and subsequently submitted a Clinical Trial Application (CTA) for its Phase 3 clinical trial in cancer patients. This trial is expected to be a landmark clinical trial and is the first of its kind, enrolling a total of 946 ...more  
Comment by TheBossCwC on Jan 29, 2018 3:53pm
Sorry for my novice html skills. Also meant to say Aphria acquires Nuuvera on Jan 29th, but Nuuvera acquired Medalchemy. In the end it looks like TBP now has access to a GMP Certified Lab which is welcomed by the company from its manufacturing partners a.k.a Aphria..... unless im way off
Comment by MaceWindu on Jan 30, 2018 10:47am
While I do like the deal as well for the long term, doesn't this mean we won't have access to the GMP we need to start PPP001 trials until April now given that the deal is expected to close in April? Please correct me if I'm wrong.
Comment by MaceWindu on Jan 30, 2018 10:49am
...assuming Aphria is not still going to pursue their own after announcing this acquisition.
Comment by Ripsanddips on Jan 30, 2018 11:20am
NUU's GMP cert is for oil HC requested GMP cert fromAPH for the API used in PPP001 2 totally different things
Comment by LeafRider on Jan 30, 2018 11:45am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities